The Second Bite of the Apple: What Is Rollover Equity Really Worth?
Updated: 13 hours ago
Who ate my apple?
Whenever I hear a first-time founder say, “I could make 2–3x on my rollover equity and get a second bite at the apple,” I think of the twenty- or thirty-something-year-old at the private equity firm who put that overused phrase in founders’ minds, and my gag reflex kicks in. Like “value-add,” “skin in the game,” or “synergy,” “second bite of the apple” has been stripped of substance.
It sounds generous. You sell most of your company today, keep a slice, and when the private equity firm sells again in four or five years, you get paid a second time. The slice is often pitched as worth 2x-5x more than the amount of equity you rolled over. In reality, it’s a tactic to pay you less cash up front, and serve more as a stick than a carrot to make you behave nicely in the future.
Here’s the thing about that apple. By the time you get that theoretical second bite, the buyer has already taken multiple bites through management fees and their preferred return (more on that later). So has the buyer's lender. So has the new management option pool. By the time you get to your slice, instead of a meaty second bite, you end up with the core.
BLUF (Bottom Line Up Front): Rollover equity is a very common component of a deal structure, and it is not uniformly good or bad. This post walks you through what rollover equity is, how it works, its risks and potential benefits, how best to evaluate its future value, and the questions you should ask about rollover equity.
1. What is rollover equity?
Rollover equity means you take part of your sale price as shares (equity) in the buyer’s new company instead of cash. Sell for $40 million, roll 20%, and you walk away with $32 million at closing plus $8 million of shares in “NewCo,” the holding company the private equity firm sets up to own your business.
William Blair (an investment bank) cites data showing 57% of deals in 2023 included rollover, up from 46% in 2020, and puts the typical middle-market rollover at 20% to 30% of the deal.
Buyers will tell you why they want it. Here’s the polite version and the real one:
Reason | What they say | What it also means |
Alignment | “We want you to have skin in the game.” | They need you running the business through the transition, and your rollover is collateral for your good behavior. It's often tied to non-compete, non-solicit, and non-hire agreements. |
Less cash at closing | “It’s a standard part of the structure.” | Every dollar you roll is a dollar they don’t have to raise from their investors or borrow from their lenders. |
Bridging the price | “We can get to your number.” | They can hit your headline valuation while handing you less of it in cash today. It's a form of risk sharing, with you, the founder, taking on more risk. |
2. How it works: an owner’s risk, an employee’s control
Here’s the uncomfortable part. After closing, you carry the risk of an owner and have almost none of an owner’s control.
You hold levered equity risk
Your rollover equity sits lowest on the capital structure as common equity, which means it's underneath a pile of new debt the buyer borrows against your company, as well as behind the cash the private equity fund puts in. In the example below, the buyer funds a $40M purchase with $20M of debt. Your $8M rollover is 20% of the price but 37% of the equity. Leverage magnifies the upside. But as Charlie Munger originally observed: "There are only three ways a smart person can go broke: liquor, ladies, and leverage."
Often your slice sits behind the private equity firm's. Many private equity firms put their own money in as preferred equity that earns a set annual return, compounding, before common shareholders see a dollar. If your rollover is common, you’re last in line at exit: lenders first, then the sponsor’s preferred and its return, then the management option pool, then you.
You give up control
Before closing, you were the boss. After closing, you’re an employee with a minority stake. In a typical control buyout, the private equity firm:
Controls the board. It holds the majority of seats, and the board approves the budget, big spending, add-on acquisitions, new debt, and the eventual sale.
Hires and fires the executives, including you. If the plan slips, the founder is often the first to go. Your equity documents may also let them buy back your shares if you leave or are fired, sometimes at the lower of cost or fair value (which, again, in some cases, is determined by the board or by a valuation firm hired by the board).
Decides when, how, and to whom to sell. Drag-along rights mean you sell when they sell, on their terms. They can also hold longer, move the company into a continuation fund, or borrow more to pay themselves a dividend.
Pays itself fees out of your company. Many private equity firms charge the companies they own an annual management or monitoring fee, usually a fixed amount each year, sometimes with an annual escalator, plus transaction fees on the original deal and every add-on acquisition. That cash comes out of the business, so it shrinks the value that’s left for every equity holder, including you. The fund collects it whether or not your rollover ever pays off.
Controls what you see. As a minority holder you may get a quarterly reporting package, or you may see nothing at all.
In the meantime, you usually can’t sell your shares to anyone. Your rollover is illiquid until the sponsor decides it isn’t.
That’s the stick. Push back too hard in a board meeting and both your job and your equity are on the line.
And the timeline to a liquidity event is entirely theirs
Four or five years is the pitch. Reality has stretched. Bain says buyout holding periods at exit are now around seven years, up from five to six years in 2010 to 2021. The industry is sitting on 32,000 unsold companies worth $3.8 trillion, and distributions to fund investors have stayed below 15% of net asset value for four straight years, a record (Bain, Feb 2026). Every extra year you wait is a year your money isn’t compounding somewhere you control.
3. Scenarios: The difference between your rollover equity being near worthless or having value
The short answer: in a perfectly okay outcome, your rollover can come back close to zero. To earn the 2–3x you were pitched, the business has to grow a lot faster than most do.
Here’s a worked example:
Term | Worked example |
Price | $40.0M ($5.0M EBITDA × 8.0x) |
Your rollover | 20% of price = $8.0M; you take $32.0M in cash |
New debt | 4.0x EBITDA = $20.0M |
Deal fees and expenses | 4% of price = $1.6M (lawyers, quality of earnings, financing fees, the fund's own transaction fee) |
Private Equity Investment | $13.6M of cash, the plug that covers whatever the debt and your rollover don't |
Preferred return | 12% a year, compounding quarterly |
Management pool | 10% of the equity value created after closing (profits interests: no cash at closing, paid after the preferred) |
Exit | Year 5 |
Two things worth noticing. First, at closing, the buyer has to pay you and pay the deal costs. The fees come out of the equity on day one: you and the fund put in $21.6M of equity to own a business you just valued at $20.0M of equity. Second, the management option pool costs nothing at closing. It’s a profits interest, so it only dilutes the gains later.
Three ways the equity gets split
How your rollover performs depends heavily on what kind of equity you get compared with the fund. There are three common structures, from best to worst for you:
Structure | What the fund holds | What you hold | What it means for you |
Strip | Preferred units earning 12%, plus common units | The same mix of preferred and common, in the same ratio | You earn exactly what the fund earns per dollar invested. If it’s a bad deal for the fund, it’s a bad deal for you, but no worse. |
Convertible preferred | Preferred earning 12%, which it can convert to common | Common | At exit the fund takes whichever is bigger: its money back plus 12%, or its share as common. Below that crossover, the fund takes everything and you get nothing. |
Participating preferred | Preferred earning 12%, plus a share of everything left over | Common | The fund gets its money back plus 12% first, then also takes its share of the rest. Your slice gets squeezed at every outcome. |
Read the operating agreement carefully. Which structure is being proposed? Negotiating which one can have a significant impact on the value of your rollover equity.
The base case: EBITDA grows modestly
Take a relatively flat outcome. EBITDA grows 3% a year. The buyer sells at 7.0x instead of the 8.0x it paid, and has paid down a bit of debt. The business sells for $40.6M, almost exactly what it cost five years earlier.
After the lenders and the bankers are paid, $22.8M of equity is left. What you get from it depends entirely on the structure:
Strip: everyone’s preferred is owed $39.0M by now (the $21.6M put in, plus 12% a year compounding). There’s only $22.8M, so it’s split pro rata. You get $8.4M back on your $8.0M, about 1% a year for five years. So does the fund.
Convertible or participating preferred: the fund’s $13.6M has quietly compounded into a $24.6M claim. That’s more than the $22.8M on the table, so the fund takes all of it and makes 1.7x. Your $8.0M rollover gets nothing.
Nobody did anything wrong here. The company didn’t fail. The structure simply decided who absorbed a flat result, and it wasn’t the private equity fund.
Another note: this is a Base Case Scenario. Bad outcomes are common. When Bain studied 117 mature buyout funds, about 30% of their completed deals didn’t return the money invested, and even in top-quartile funds 23% lost money (Bain, 2013). A fund’s investors get the blend of 15 companies. You get one.
4. Which buyers make your rollover worth anything?
Your rollover is only as good as the private equity firm that you partner with. On average, private equity hasn’t beaten the stock market for a long time. The best firms do, and the evidence says it’s far easier to spot a bad one than to bet on a good one.
On average, private equity doesn’t do great
To be fair, the industry earned its reputation. A widely cited study by Harris, Jenkinson and Kaplan found the average US buyout fund beat the S&P 500 by 20% to 27% over its life, or more than 3% a year. Then the newer data showed up:
About the same as stocks since 2006. Oxford professor Ludovic Phalippou found large pension funds earned roughly $1.50 for every $1 put into private equity since 2006, net of fees, which is about what public stocks returned (PLANSPONSOR). Fund managers collected an estimated $230 billion in carried interest along the way.
Behind the S&P over the last decade. Bain’s 2026 report says US stocks have outperformed average buyout returns over the past ten years (Bain, Feb 2026). Said differently, if you got more cash at close, you could invest it in the S&P and earn more than your rollover equity (and it would be significantly less leveraged and more diversified).
Roughly a leveraged index fund. AQR found buyouts beat large-cap stocks by 2.3% a year from 1986 to 2017, but beat a 1.2x leveraged small-cap index by just 0.7% and trailed a basket of small value stocks (AQR).
But averages hide a huge spread. Bain notes top-quartile buyout funds still beat public markets by a wide margin. Your job is to figure out which kind of firm is across the table.
The questions to ask before you agree to roll your equity
They just spent months picking through your books. It's your turn to do your due diligence on them.
Where are you in your fund cycle? Which fund will own my company, what year did it start investing, and how much is left to invest? A typical fund has a ten-year life. A firm buying late in a fund may need to sell early, or push your company into a continuation fund instead of selling it. A firm out raising its next fund needs its first few investments to do great.
What have your previous funds returned, gross and net, in cash? Ask for each prior fund’s gross and net multiple, and its DPI (distributions to paid-in capital, the cash actually returned to investors). The gap between gross and net is fees and carry. Unrealized value is the firm’s own estimate.
How many of your deals returned less than 1x? And what happened to the founders who rolled in those deals?
Can I talk to founders who have sold to you? Ask for the list, then find a few on your own, including one whose company sold for a disappointing number. The references they hand you are like employee references, so watch for cherry-picking.
What exactly am I getting? Do I get the same securities as the sponsor, in the same mix of preferred and common? Is there a preferred return, at what rate, and does it compound? How big is the management pool? Can I invest alongside new equity, or do I get diluted? What happens to my shares if I’m fired? Do I have tag-along and information rights?
If the answers are good, a bigger rollover can make sense. If they’re vague, or you can’t get them, focus on the other lever: push the cash at closing as high as you can, to a number you’d be happy with if the rollover went to zero.
The bottom line
Rollover equity isn’t a gift, and it isn’t a scam. It’s a leveraged, illiquid bet on one company, run by someone else, on their timeline, with a structure that decides who gets paid first. With the right firm and the right terms, it can be the best check you ever cash. With the wrong ones, you’re left holding the apple core.
So take the first bite seriously. Diligence the buyer as hard as they diligenced you, get the cash at closing to a number you’d be happy with if the rollover went to zero, and treat anything you get back as dessert.
This post is for education only. It isn't investment, tax or legal advice. Have your own advisers review your actual deal documents.
Sources
Bain & Company, Private Equity Outlook 2026: Gaining Traction, Global Private Equity Report 2026 (Feb 2026)
Bain & Company, 2026 Midyear PE report press release (June 2026)
Bain & Company, Top private equity funds mine past wins for lessons (2013)
Ilmanen, Chandra & McQuinn (AQR), Demystifying Illiquid Assets: Expected Returns for Private Equity, Journal of Alternative Investments (Winter 2020)
PLANSPONSOR, Study Suggests Private Equity Doesn't Outperform Stock Indices, on Phalippou's "An Inconvenient Fact" (June 2020)
NBER Digest, Private Equity Performance, on Harris, Jenkinson & Kaplan (2012)
William Blair, Rollover Equity and Wealth Planning Considerations (Sept 2025)
Harris, Jenkinson, Kaplan & Stucke, Has Persistence Persisted in Private Equity? Evidence from Buyout and Venture Capital Funds, NBER Working Paper 28109 (2020)
Comments